Text | Zhou Xinyu
Editor | Su Jianxun
36 Krypton learned that recently the SOD manufacturer “Extraordinary Biotechnology” received a Pre-A round of financing of tens of millions of RMB. This financing was led by Mangosteen Capital, and other industrial investment institutions jointly invested.
Driven by daily chemical products such as “Dabao SOD Honey”, the concept of SOD has become popular. As the “scavenger” of the human body, SOD, whose full name is superoxide dismutase, can regulate oxidative metabolism and anti-aging functions in the body by removing excessive strong oxidative substances and superoxide free radicals that cause aging in the body.
Founded in 1998, Feifan Biotechnology was led by Huang Youying, a professor at the School of Life Sciences of Southwest University for Nationalities. Through the closed-loop layout of the industrial chain combining production, learning, research and application, it has built a SOD basic technology research and development platform, industrialization platform and commercialization platform. , R&D, production and sales of technological health products with SOD as the key active ingredient.
SOD produced by traditional plant extraction methods has the pain points of poor tolerance, low purity, and difficulty in preservation. Once affected by environmental factors such as temperature, acidity and alkalinity, it will quickly lose its activity. The three major problems of “difficult to extract, difficult to store, and difficult to absorb” have also plagued SOD manufacturers for nearly 40 years, greatly limiting the application scenarios of SOD.
Relying on years of professional research on enzyme engineering and polysaccharide engineering, Feifan Biotechnology has solved the three worldwide problems of SOD “difficult to extract, difficult to absorb, and difficult to keep alive”.
According to Jiang Shihao, President of Extraordinary Biotechnology, in order to solve the problem of difficulty in keeping alive, the team adopted wrapping technology to wrap a layer of acid, alkali and high temperature resistant film coating on the outside of SOD to protect SOD from being decomposed by gastric acid. Since SOD is a macromolecule, it is difficult for the human body to absorb it, so Extraordinary Biology has cut SOD.
Due to the lack of specific recognition of tumor cells, SOD has not been applied to the clinical treatment of tumors. In other words, once the positioning problem is solved, SOD can play a greater role in tumor treatment and inflammation elimination.
At present, the extraordinary biotechnology team has solved the problem of SOD’s targeting effect through genetic engineering methods and covalent technology. As of November 2022, the company has more than 503 authorized and applied patents.
However, benefiting from the development of downstream medicine, beauty, and food industries, the demand for SOD in my country continues to grow.
Jiang Shihao told 36 Krypton that at present, the main products of Feifan Biotechnology include two major services for the B-end and C-end. Facing the B-side, Feifan Biotechnology is mainly engaged in the fine processing of SOD and the export of raw materials. In recent years, with the improvement of people’s health awareness, Feifan Biotechnology has gradually shifted its business center to OFO retail of SOD functional food.
With the help of capital, Feifan Biotechnology will rely on SOD products and technology to develop self-developed drugs (OTC drugs) or second and third types of medical devices and realize sales in the future, expanding the company’s products (including consumer products, OTC drugs, and medical device products) To public hospitals, medical beauty institutions, Internet medical institutions, clinics and pharmacies, expand the company’s SOD raw materials to other drug/medical device R&D and production institutions, and become a SOD raw material supplier for drug/medical device R&D and production institutions.
With the injection of mangosteen capital, Extraordinary Biotechnology will accelerate the realization of the full coverage of the national distribution system, and gradually transform from “quantity expansion” to “fine empowerment”. In view of the positioning of biotechnology companies, Viva Biotechnology will enter the medical field at the market end, and make the medical market business the cornerstone of the company’s brand equity.
Chen Jun, partner of Mangosteen Capital, said:
The SOD industry of Extraordinary Biotechnology is a brand-new sunrise industry. It has the R&D and production technology of SOD raw materials supported by the core intellectual property system, and the SOD productization technology for different application scenarios, which constitutes the most solid foundation for the capitalization of Extraordinary Biotechnology. Base. Especially in the post-epidemic era, medical resources are being run out, and the whole people are aware of the importance of enhancing immunity. People’s demand for improving immunity is blowing out. We look forward to seeing the SOD industry of extraordinary biotechnology develop better, so that more To benefit the people, Feifan adheres to the national “green development” policy to promote the harmonious coexistence between man and nature. In the near future, Feifan biotechnology will become the industry benchmark and lead the health industry, allowing SOD healthy food to enter thousands of households.
media reports
Venture State 36Kr in the investment world
related events
- “Extraordinary Biotechnology” completed the Pre-A round of financing of tens of millions of yuan, led by Mangosteen Capital2023-01-11
- Hong Kong Stock Exchange Li Xiaojia : Consider including biotechnology companies in the interconnection2020-09-27
- “Suikun Smart” completed tens of millions of RMB Pre-A round of financing, led by Heyu Capital2019-11-23
- Beimenji Biotechnology completed tens of millions of RMB in Series B financing2019-08-27
- Ginkgo, a biotechnology start-up company, completed financing of 275 million US dollars2017-12-15
This article is transferred from: https://readhub.cn/topic/8msmDDMQqOA
This site is only for collection, and the copyright belongs to the original author.